Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis

Detalhes bibliográficos
Autor(a) principal: Mirzaee, Shahla
Data de Publicação: 2019
Outros Autores: Golestannejad, Zahra, Sadeghian, Rastin, Rohani, Bita, Sadeghian, Saeid
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Dental Science
Texto Completo: https://ojs.ict.unesp.br/index.php/cob/article/view/1837
Resumo: Objective: Recurrent aphthous stomatitis (RAS) is characterized by recurring ulcers, with well-defined margins. The lesions are confined to the oral mucosa (usually seen in non-keratinized mucosa). The disease manifests in the form of outbreaks, with a chronic and self-limiting course in most cases. Since the cause of the disease is unknown, many drugs have been studied to palliate the symptoms. Treatment used is multifocal and varies according to the predisposing factors. The aim of this study was to investigate the effect of recombinant Nano-based triamcinolone acetonide gel and compare it with conventional triamcinolone gel on RAS. Material and methods: In this triple-blind randomized clinical trial study, sixty patients with minor aphthous lesions were divided into two groups receiving conventional triamcinolone (CT) and Nano-based triamcinolone (NT). The patients were requested to apply drug four times a day for a week. The severity of pain (through VAS) and the size of the lesions (mean of the largest diameter of the lesions) were evaluated on starting day and days 2, 4, 6 after the intervention. Statistical analysis was performed using chi square and independent t-test. Findings were significant with P < 0.05. Findings: Of the 60 patients enrolled in the study, 5 patients did not continue; 21 (38.2%) cases were female and 34 (61.8%) cases were male (P=0.6). The severity of pain in NT group before and after the study was 1.4 ± 5.2 and 1.8 ± 1.3 cm, respectively and in CT group was 48.1 ± 1 and 1.8 ± 1.3 cm. The size of the lesions in NT group before and at the end of the study was 0.96 ± 0.1 and 0.18 ± 0.1   cm, respectively and in CT group was 0.93 ± 0.1 and 0.19 ± 0.1 cm.  Among the mentioned variables, only size of lesions on the 2nd and 4th days had a significant reduction in NT group in comparison with CT group. Conclusion: The size of lesions showed a significant reduction on the 2nd and 4th days in NT group in comparison with CT group, therefore NT has a better impact on RAS in comparison with CT.KEYWORDSNanoparticle; Recurrent aphthous stomatitis; Treatment; Triamcinolone.
id UNESP-20_6a102fe0fbbd257c9f16a7795ae0ab6d
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1837
network_acronym_str UNESP-20
network_name_str Brazilian Dental Science
repository_id_str
spelling Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitisObjective: Recurrent aphthous stomatitis (RAS) is characterized by recurring ulcers, with well-defined margins. The lesions are confined to the oral mucosa (usually seen in non-keratinized mucosa). The disease manifests in the form of outbreaks, with a chronic and self-limiting course in most cases. Since the cause of the disease is unknown, many drugs have been studied to palliate the symptoms. Treatment used is multifocal and varies according to the predisposing factors. The aim of this study was to investigate the effect of recombinant Nano-based triamcinolone acetonide gel and compare it with conventional triamcinolone gel on RAS. Material and methods: In this triple-blind randomized clinical trial study, sixty patients with minor aphthous lesions were divided into two groups receiving conventional triamcinolone (CT) and Nano-based triamcinolone (NT). The patients were requested to apply drug four times a day for a week. The severity of pain (through VAS) and the size of the lesions (mean of the largest diameter of the lesions) were evaluated on starting day and days 2, 4, 6 after the intervention. Statistical analysis was performed using chi square and independent t-test. Findings were significant with P < 0.05. Findings: Of the 60 patients enrolled in the study, 5 patients did not continue; 21 (38.2%) cases were female and 34 (61.8%) cases were male (P=0.6). The severity of pain in NT group before and after the study was 1.4 ± 5.2 and 1.8 ± 1.3 cm, respectively and in CT group was 48.1 ± 1 and 1.8 ± 1.3 cm. The size of the lesions in NT group before and at the end of the study was 0.96 ± 0.1 and 0.18 ± 0.1   cm, respectively and in CT group was 0.93 ± 0.1 and 0.19 ± 0.1 cm.  Among the mentioned variables, only size of lesions on the 2nd and 4th days had a significant reduction in NT group in comparison with CT group. Conclusion: The size of lesions showed a significant reduction on the 2nd and 4th days in NT group in comparison with CT group, therefore NT has a better impact on RAS in comparison with CT.KEYWORDSNanoparticle; Recurrent aphthous stomatitis; Treatment; Triamcinolone.Institute of Science and Technology of São José dos Campos2019-10-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfimage/jpegapplication/vnd.openxmlformats-officedocument.wordprocessingml.documenthttps://ojs.ict.unesp.br/index.php/cob/article/view/183710.14295/bds.2019.v22i4.1837Brazilian Dental Science; Vol. 22 No. 4 (2019): Oct. - Dec. / 2019 - Published October 2019; 554-560Brazilian Dental Science; v. 22 n. 4 (2019): Oct. - Dec. / 2019 - Published October 2019; 554-5602178-6011reponame:Brazilian Dental Scienceinstname:Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)instacron:UNESPenghttps://ojs.ict.unesp.br/index.php/cob/article/view/1837/1421https://ojs.ict.unesp.br/index.php/cob/article/view/1837/3852https://ojs.ict.unesp.br/index.php/cob/article/view/1837/3853Copyright (c) 2019 Brazilian Dental Scienceinfo:eu-repo/semantics/openAccessMirzaee, ShahlaGolestannejad, ZahraSadeghian, RastinRohani, BitaSadeghian, Saeid2020-01-23T17:39:02Zoai:ojs.pkp.sfu.ca:article/1837Revistahttp://bds.ict.unesp.br/PUBhttp://ojs.fosjc.unesp.br/index.php/index/oaisergio@fosjc.unesp.br||sergio@fosjc.unesp.br2178-60112178-6011opendoar:2022-11-08T16:30:25.129906Brazilian Dental Science - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)true
dc.title.none.fl_str_mv Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
title Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
spellingShingle Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
Mirzaee, Shahla
title_short Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
title_full Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
title_fullStr Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
title_full_unstemmed Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
title_sort Comparison of therapeutic effect of mucoadhesive Nano-triamcinolone gel and conventional triamcinolone gel on recurrent aphthous stomatitis
author Mirzaee, Shahla
author_facet Mirzaee, Shahla
Golestannejad, Zahra
Sadeghian, Rastin
Rohani, Bita
Sadeghian, Saeid
author_role author
author2 Golestannejad, Zahra
Sadeghian, Rastin
Rohani, Bita
Sadeghian, Saeid
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Mirzaee, Shahla
Golestannejad, Zahra
Sadeghian, Rastin
Rohani, Bita
Sadeghian, Saeid
description Objective: Recurrent aphthous stomatitis (RAS) is characterized by recurring ulcers, with well-defined margins. The lesions are confined to the oral mucosa (usually seen in non-keratinized mucosa). The disease manifests in the form of outbreaks, with a chronic and self-limiting course in most cases. Since the cause of the disease is unknown, many drugs have been studied to palliate the symptoms. Treatment used is multifocal and varies according to the predisposing factors. The aim of this study was to investigate the effect of recombinant Nano-based triamcinolone acetonide gel and compare it with conventional triamcinolone gel on RAS. Material and methods: In this triple-blind randomized clinical trial study, sixty patients with minor aphthous lesions were divided into two groups receiving conventional triamcinolone (CT) and Nano-based triamcinolone (NT). The patients were requested to apply drug four times a day for a week. The severity of pain (through VAS) and the size of the lesions (mean of the largest diameter of the lesions) were evaluated on starting day and days 2, 4, 6 after the intervention. Statistical analysis was performed using chi square and independent t-test. Findings were significant with P < 0.05. Findings: Of the 60 patients enrolled in the study, 5 patients did not continue; 21 (38.2%) cases were female and 34 (61.8%) cases were male (P=0.6). The severity of pain in NT group before and after the study was 1.4 ± 5.2 and 1.8 ± 1.3 cm, respectively and in CT group was 48.1 ± 1 and 1.8 ± 1.3 cm. The size of the lesions in NT group before and at the end of the study was 0.96 ± 0.1 and 0.18 ± 0.1   cm, respectively and in CT group was 0.93 ± 0.1 and 0.19 ± 0.1 cm.  Among the mentioned variables, only size of lesions on the 2nd and 4th days had a significant reduction in NT group in comparison with CT group. Conclusion: The size of lesions showed a significant reduction on the 2nd and 4th days in NT group in comparison with CT group, therefore NT has a better impact on RAS in comparison with CT.KEYWORDSNanoparticle; Recurrent aphthous stomatitis; Treatment; Triamcinolone.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://ojs.ict.unesp.br/index.php/cob/article/view/1837
10.14295/bds.2019.v22i4.1837
url https://ojs.ict.unesp.br/index.php/cob/article/view/1837
identifier_str_mv 10.14295/bds.2019.v22i4.1837
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://ojs.ict.unesp.br/index.php/cob/article/view/1837/1421
https://ojs.ict.unesp.br/index.php/cob/article/view/1837/3852
https://ojs.ict.unesp.br/index.php/cob/article/view/1837/3853
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Dental Science
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Dental Science
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
image/jpeg
application/vnd.openxmlformats-officedocument.wordprocessingml.document
dc.publisher.none.fl_str_mv Institute of Science and Technology of São José dos Campos
publisher.none.fl_str_mv Institute of Science and Technology of São José dos Campos
dc.source.none.fl_str_mv Brazilian Dental Science; Vol. 22 No. 4 (2019): Oct. - Dec. / 2019 - Published October 2019; 554-560
Brazilian Dental Science; v. 22 n. 4 (2019): Oct. - Dec. / 2019 - Published October 2019; 554-560
2178-6011
reponame:Brazilian Dental Science
instname:Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Brazilian Dental Science
collection Brazilian Dental Science
repository.name.fl_str_mv Brazilian Dental Science - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
repository.mail.fl_str_mv sergio@fosjc.unesp.br||sergio@fosjc.unesp.br
_version_ 1788346901171535872